Why You Might Be Gaining Weight on Wegovy — and What It Means

Is what you're seeing actually weight gain, or a plateau?

The scale going up by a kilogram or two across a few days is almost always water, food volume, or hormonal fluctuation rather than genuine fat regain. A practical check worth doing right now: look at your trend over three to four weeks, not the last three days. One reading means very little. Weekly averages, taken at the same time of day under the same conditions, tell a far more honest story.

True weight gain while on Wegovy (sustained upward movement over several weeks) does happen, but it is rarer than the forums suggest. A plateau, where loss stalls but nothing is increasing, is much more common. The two feel similar but have different causes and different responses. If your weight has been genuinely rising for three or more weeks and you have not recently changed dose, that is worth raising with your prescriber rather than adjusting anything yourself.

The causes of gaining weight while on Wegovy can be more specific than they first appear, dose timing, injection technique, and concurrent medicines all feature on that list.

Why does weight sometimes go up on semaglutide rather than down?

Semaglutide works by activating GLP-1 receptors, which slow gastric emptying, reduce appetite signals, and improve glucose regulation, as the NHS semaglutide medicines page explains. But the medicine does not override every physiological driver of weight. A few specific situations can tip the balance the wrong way.

First, dose level matters. Earlier in the titration schedule, appetite suppression is modest. Some people overcompensate during the starter phase, eating slightly more because nausea has eased but the appetite-reduction effect is not yet at full strength. Second, corticosteroids, certain antidepressants (particularly mirtazapine), some antipsychotics, and insulin secretagogues can drive weight gain through mechanisms entirely separate from hunger. If a new medicine joined your routine around the time the scale started moving up, that connection is worth exploring with whoever prescribes it. Third, disrupted sleep and sustained high stress both raise cortisol, which promotes fat storage and appetite, neither of those bends to semaglutide's mechanism. Fourth, there is a small group of people who simply do not respond as well to semaglutide. NICE's appraisal of semaglutide for weight management (TA875) includes the recommendation that continuation should be reconsidered if less than 5% weight loss is achieved after six months at the maintenance dose, a clinician makes that assessment, not the patient.

If you are unsure whether your dose is working as it should, the detailed look at why weight gain happens on Wegovy covers the clinical picture in more depth.

What should you actually do if you're gaining weight with Wegovy?

The first thing is not to stop the injections without speaking to your prescriber. Stopping abruptly removes the appetite suppression that has been modulating your intake, and weight can return quickly. The research on what happens when treatment ends is documented, see the section on gaining weight after stopping Wegovy for the specifics.

Before contacting your prescriber, pull together a short picture: how long has weight been rising, roughly how many weekly doses have been taken on schedule, whether any new medicines started recently, and whether sleep or stress have changed. That information cuts the consultation short and gets you to an answer faster. Missed or delayed injections are worth flagging too, semaglutide's effect tapers between doses, and gaps create windows where appetite bounces back.

From a lifestyle standpoint, protein intake is the most evidence-consistent lever during GLP-1 treatment. Appetite suppression can lead people to eat too little overall and too little protein in particular, which costs muscle, and muscle is the tissue most responsible for resting energy expenditure. Strength activity helps preserve it, and it also plays a role in managing the skin changes that can accompany wegovy-related weight loss. These are not replacements for a clinical conversation; they are the practical context your prescriber will likely ask about anyway.

If you are considering costs as part of your decision about staying on treatment, our guide to Wegovy pricing in the UK sets out what legitimate private prescriptions include and why headline prices can be misleading.

What about weight that comes back after Wegovy, is that different?

Yes, and it is worth distinguishing clearly. Regain after stopping Wegovy is a well-documented pattern, semaglutide does not produce permanent changes to the underlying biology that drives weight. When the medicine stops, hunger signals tend to return to pre-treatment levels over weeks to months, and weight follows. This is not a personal failure; it reflects how GLP-1 medicines interact with appetite physiology.

If you are experiencing weight creep in the months after your last injection rather than during active treatment, that is a separate question from gaining weight on Wegovy. The guide to weight gain after Wegovy addresses the post-treatment period, including what options exist if you are considering restarting.

Active treatment that is not delivering results is a different clinical situation from stopped treatment where weight is returning. The distinction shapes what options make sense, and that conversation starts with a prescriber who has the full picture. Check your eligibility for a consultation if you are weighing up whether to continue, restart, or switch.